2008•Medical Journal of West ChinaRequires access

Enalapril and metoprolol in treatment of heart failure

Zhiqing Zhang

Open publisher page 0 citations

Abstract

Objective To observe clinical effect of angiotensin converting enzyme inhibitors(ACEI)-enalapril and selective β-blocker-metoprolol in treatment of heart failure.Methods 60 patients were randomly divided into two groups,including control group(30 cases) and treatment group(30 cased).Besides routine treatments,control group gave isosorbide dinitrate and digoxin,whereas treatment group gave enalapril and metoprolol.Before and after treatment by NYHA classification,left ventricular end diastolic diameter(LVEDD),left ventricular end systolic diameter(LVESD),ejection fraction(EF) and A/E ratio were detected with color Doppler echocardiography to evaluated the heart function.Results Treatment group was improved more obviously in diastolic diameter and ejection fraction than that in control group.Conclusion Enalapril and metoprolol is a useful drug for cardiac insufficiency.

About this research paper

What this paper is about

Objective To observe clinical effect of angiotensin converting enzyme inhibitors(ACEI)-enalapril and selective β-blocker-metoprolol in treatment of heart failure.Methods 60 patients were randomly divided into two groups,including control group(30 cases) and treatment group(30 cased).Besides routine treatments,control group gave isosorbide dinitrate and digoxin,whereas treatment group gave enalapril and metoprolol.Before and after treatment by NYHA classification,left ventricular end diastolic diameter(LVEDD),left ventricular end systolic diameter(LVESD),ejection fraction(EF) and A/E ratio were detected with color Doppler echocardiography to evaluated the heart function.Results Treatment group was improved more obviously in diastolic diameter and ejection fraction than that in control group.Conclusion Enalapril and metoprolol is a useful drug for cardiac insufficiency.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe clinical effect of angiotensin converting enzyme inhibitors(ACEI)-enalapril and selective β-blocker-metoprolol in treatment of heart failure.Methods 60 patients were randomly divided into two groups,including control group(30 cases) and treatment group(30 cased).Besides routine treatments,control group gave isosorbide dinitrate and digoxin,whereas treatment group gave enalapril and metoprolol.Before and after treatment by NYHA classification,left ventricular end diastolic diameter(LVEDD),left ventricular end systolic diameter(LVESD),ejection fraction(EF) and A/E ratio were detected with color Doppler echocardiography to evaluated the heart function.Results Treatment group was improved more obviously in diastolic diameter and ejection fraction than that in control group.Conclusion Enalapril and metoprolol is a useful drug for cardiac insufficiency.

Key concepts: Metoprolol, Enalapril, Medicine, Ejection fraction, Digoxin, Cardiology, Isosorbide dinitrate, Heart failure

Related papers

Back to paper searchBrowse research topicsOriginal source
Enalapril and metoprolol in treatment of heart failure — Research Paper | ScholarLens